MedPath

Liothyronine Sodium

Liothyronine Sodium Tablets, USP

Approved
Approval ID

4a8f7bf4-fa8f-4cde-9be2-11d5a4e6f07f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 9, 2014

Manufacturers
FDA

Aidarex Pharmaceuticals LLC

DUNS: 801503249

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Liothyronine Sodium

PRODUCT DETAILS

NDC Product Code33261-964
Application NumberANDA090097
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJanuary 9, 2014
Generic NameLiothyronine Sodium

INGREDIENTS (6)

LIOTHYRONINE SODIUMActive
Quantity: 5 ug in 1 1
Code: GCA9VV7D2N
Classification: ACTIM
CALCIUM SULFATEInactive
Code: WAT0DDB505
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
© Copyright 2025. All Rights Reserved by MedPath
Liothyronine Sodium - FDA Approval | MedPath